STELLATE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, January 15, 2020, a trademark application was filed for STELLATE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the STELLATE THERAPEUTICS trademark a serial number of 88983879. The federal status of this trademark filing is REGISTERED as of Tuesday, May 3, 2022. This trademark is owned by Amabiotics Inc.. The STELLATE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; medical and scientific research in the fields of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
stellate therapeutics

General Information

Serial Number88983879
Word MarkSTELLATE THERAPEUTICS
Filing DateWednesday, January 15, 2020
Status700 - REGISTERED
Status DateTuesday, May 3, 2022
Registration Number6719570
Registration DateTuesday, May 3, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; medical and scientific research in the fields of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code042
First Use Anywhere DateSunday, May 31, 2020
First Use In Commerce DateSunday, May 31, 2020

Trademark Owner History

Party NameSTELLATE THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10013
Party NameSTELLATE THERAPEUTICS INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10013
Party NameSTELLATE THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameAmabiotics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameAmabiotics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events

Event DateEvent Description
Tuesday, May 3, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, March 31, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, January 21, 2022USE AMENDMENT FILED
Friday, January 21, 2022SOU EXTENSION 3 GRANTED
Friday, January 21, 2022SOU EXTENSION 3 FILED
Wednesday, March 2, 2022DIVISIONAL PROCESSING COMPLETE
Friday, January 21, 2022DIVISIONAL REQUEST RECEIVED
Friday, January 21, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 21, 2022TEAS STATEMENT OF USE RECEIVED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 14, 2021SOU EXTENSION 2 FILED
Wednesday, July 14, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 3, 2021SOU EXTENSION 1 GRANTED
Friday, January 8, 2021SOU EXTENSION 1 FILED
Thursday, January 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 17, 2020ASSIGNED TO LIE
Tuesday, April 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, April 2, 2020ASSIGNED TO EXAMINER
Wednesday, January 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 18, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics stellate disorders disease diseases related research parkinson alzheimer ataxia huntington sclerosis